Hers launches a GLP‑1 weight loss membership starting at $39. Here’s how the program works, what’s included, and who may ...

You don’t need me to tell you about the widespread popularity of GLP-1 drugs. We’ve reached a point where anyone who loses a ...

New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored ...

The study found that the drug stimulates insulin secretion, suppresses appetite and increases satisfaction to promote weight ...

Some Medicare beneficiaries could soon pay a flat $50 for GLP-1 drugs. Learn who qualifies, what employers may do, and what ...

GLP-1 weight-loss drugs will cost $50 a month for many older adults starting July 1, as Medicare begins to cover them. How ...

Medicare’s pilot program set to offer eligible Part D beneficiaries GLP-1 therapies for weight loss—read more.

Early-stage research suggests drugs like Ozempic, Wegovy, Zepbound, and Mounjaro can lower the odds of developing certain ...

Before you jump at this opportunity, make sure you know what you're signing up for.

Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

GLP-1 agonists are FDA-approved for weight management and diabetes care in certain populations. The drugs alter how the body ...

Jenny Mollen is still traumatized by her GLP-1 experience after she was hospitalized with blood clots. “I was microdosing the ...